This topic contains a solution. Click here to go to the answer

Author Question: Tasha decides that when homes in her neighborhood are selling for 150,000 she will not sell her ... (Read 141 times)

EY67

  • Hero Member
  • *****
  • Posts: 531
Tasha decides that when homes in her neighborhood are selling for 150,000 she will not sell her home. When average prices rise to 175,000, she decides that she will put her home on the market. This is an example of:
 a. market demand.
  b. market-day supply.
  c. an excess supply of homes.
  d. a positively-sloped supply curve.
  e. a negatively-sloped supply curve.

Question 2

With an upward-sloping supply curve, which of the following is true?
 a. An increase in price results in a decrease in quantity supplied.
  b. An increase in price results in an increase in supply.
  c. A decrease in price results in a decrease in quantity supplied.
  d. A decrease in price results in an increase in supply.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

paavo

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

d

Answer to Question 2

c




paavo

  • Sr. Member
  • ****
  • Posts: 301

 

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library